Breast Cancer–Related Lymphedema: the Prospective Surveillance Model, Early Intervention Strategies, and Role of Complete Decongestive Therapy-Reference-Cited by-同舟云学术

Breast Cancer–Related Lymphedema: the Prospective Surveillance Model, Early Intervention Strategies, and Role of Complete Decongestive Therapy

Published:2023-01-30 Issue:1 Volume:15 Page:12-23
ISSN:1943-4588
Container-title:Current Breast Cancer Reports
language:en
Short-container-title:Curr Breast Cancer Rep

Author:

Brunelle Cheryl L.^ORCID,Taghian Alphonse G.

Funder

National Cancer Institute

The Olayan-Xefos Family Fund for Breast Cancer Research

Heinz Family Foundation

The Adele McKinnon Research Fund for Breast Cancer-Related Lymphedema

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s12609-023-00471-9.pdf

Reference86 articles.

1. • Naoum GE, Roberts S, Brunelle CL, Shui AM, Salama L, Daniell K, et al. Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial. J Clin Oncol. 2020;38(29):3430–8. This study analyzing data from 1815 patients treated for breast cancer and screened for lymphedema was pivotal in showing that although regional lymph node radiation (RLNR) increases lymphedema risk, the main risk factor is the type of axillary surgery. The axillary lymph node dissection (ALND)-alone group had a significantly higher lymphedema risk compared with the sentinel lymph node biopsy (SLNB) and regional nodal radiation (RLNR) group. There was no significant difference in lymphedema risk between the ALND+RLNR and ALND-alone groups and between the SLNB-alone and SLNB+RLNR groups. This study allows for lymphedema risk stratification, thereby individualizing prospective screening and patient education based on breast cancer treatment received.

2. Brunelle CL, Roberts SA, Horick NK, Gillespie TC, Jacobs JM, Daniell KM, et al. Integrating Symptoms Into the Diagnostic Criteria for Breast Cancer-Related Lymphedema: Applying Results From a Prospective Surveillance Program. Phys Ther [Internet]. 2020;100(12):2186–97. https://doi.org/10.1093/ptj/pzaa162.

3. Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52(6):370–9.

4. Lymphology IS of. Consensus document of the International Society of Lymphology. Lymphology. 2020;53:3–19.

5. Brunelle CL, Gillespie TC, Bucci LK, Havens L, Bernstein M, Taghian AG. Prospective screening for breast cancer-related lymphedema. In: National Lymphedema Network Conference, June 13–15 2019. Chicago, IL; 2019.